Gulaver, Terissa T.

HRN: 24-19-27  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2023
CEFTRIAXONE 1G (VIAL)
12/06/2023
12/12/2023
IVT
2gms
Q24
Complicated Uti, Dm Ty
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: